Literature DB >> 5342

Inhibition of food-stimulated gastric acid secretion by cimetidine.

R E Pounder, J G Williams, R C Russell, G J Milton-Thompson, J J Misiewicz.   

Abstract

The effect of cimetidine, a new histamine H2-receptor antagonist, on gastric acid secretion stimulated by a homogenised meal was studied in six normal volunteers using an in vivo intragastric titration technique. The subjects were studied twice, no more than 48 h apart, receiving either cimetidine 200 mg or placebo in random order. Cimetidine administered either 32 men before (three subjects) or with the meal (three subjects) significantly inhibited gastric acid secretion in all the subjects throughout the period of study; 96 min after food, total acid secretion decreased by 67 and 57% respectively. When the drug was taken with the meal absorption was slower (mean peak blood level 2-34 mumol/l, 80-128 min after dosing) than when administered on an empty stomach (mean peak blood level 5-08 mumol/l, 48-64 min after dosing). Blood cimetidine concentration correlated significantly (P less than 0-01) with percentage inhibition of acid output and the calculated concentration resulting in 50% inhibition of gastric acid secretion (IC50) was 1-6 mumol/l. Secretion of gastrin in response to food was unaffected by cimetidine. The results suggest that 200 mg cimetidine effectively inhibits food-stimulated acid secretion and that the bioavailability of the drug may be affected by the timing of dosage in relation to meals. No unwanted effect were observed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 5342      PMCID: PMC1411161          DOI: 10.1136/gut.17.3.161

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  8 in total

1.  EFFECT OF DIFFERENT FOODS ON THE ACIDITY OF THE GASTRIC CONTENTS IN PATIENTS WITH DUODENAL ULCER. I. A COMPARISON BETWEEN TWO 'THERAPEUTIC' DIETS AND FREELY-CHOSEN MEALS.

Authors:  J E LENNARD-JONES; N BABOURIS
Journal:  Gut       Date:  1965-04       Impact factor: 23.059

2.  Effect of cimetidine on 24-hour intragastric acidity in normal subjects.

Authors:  R E Pounder; J G Williams; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1976-02       Impact factor: 23.059

3.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

4.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

5.  Metiamide, an H2-receptor blocker, as inhibitor of basal and meal-stimulated gastric acid secretion in patients with duodenal ulcer.

Authors:  M Mainardi; V Maxwell; R A Sturdevant; J I Isenberg
Journal:  N Engl J Med       Date:  1974-08-22       Impact factor: 91.245

6.  The effect of an H2-receptor antagonist on food-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcers. Comparison with an anticholinergic drug.

Authors:  C T Richardson; B A Bailey; J H Walsh; J S Fordtran
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

7.  Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer.

Authors:  R M Henn; J I Isenberg; V Maxwell; R A Sturdevant
Journal:  N Engl J Med       Date:  1975-08-21       Impact factor: 91.245

8.  Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer.

Authors:  J S Fordtran; J H Walsh
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

  8 in total
  24 in total

1.  Cimetidine and ulcers.

Authors: 
Journal:  Br Med J       Date:  1976-11-27

Review 2.  Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.

Authors:  J H Lin
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 3.  Dosage regimen of cimetidine reviewed. Possible drug accumulation after multiple oral doses.

Authors:  J Prandota; I J Smith; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 4.  Gastroenterology in the armed forces.

Authors:  G Milton-Thompson
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

5.  Anti-ulcer therapy. Past to present.

Authors:  A Bettarello
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

6.  Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist.

Authors:  J G Mills; P L Brunet; R Griffiths; R H Hunt; D Vincent; G J Milton-Thompson; W L Burland
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

7.  Inhibitory effect of cimetidine on gastric acid secretion vagally activated by physiological means in duodenal ulcer patients.

Authors:  I M Schöön; L Olbe
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

Review 8.  Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-02       Impact factor: 9.546

9.  Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study.

Authors:  M Deakin; H P Glenny; J K Ramage; J G Mills; W L Burland; J G Williams
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

10.  The effects of chronic oral cimetidine therapy on the cardiovascular system in man.

Authors:  S Saltissi; A Crowther; C Byrne; D J Coltart
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.